Reflex Sympathetic Dystrophy Surgery Medication

  • Author: Satishchandra Kale; Chief Editor: Mary Ann E Keenan, MD   more...
 
Updated: May 22, 2012
 

Medication Summary

In patients with reflex sympathetic dystrophy, the goals of pharmacotherapy are to reduce morbidity and prevent complications.

Next

Sympatholytic drugs

Class Summary

Suppress sympathetic nerve function / noradrenaline inhibitor.

Reserpine (Serpalan)

 

Inhibits vesicular uptake of noradrenaline and thus stops excitation of sympathetic nervous system; inhibits beta-hydroxylation of dopamine to noradrenaline.

Lewis et al reported good results in 90% of patients at 18 months, with 93% of patients experiencing pain relief.

Previous
Next

Alpha-adrenergic blocking agents

Class Summary

May exert effect by causing blockade of postganglionic synapses.

Phenoxybenzamine (Dibenzyline)

 

May have effect through long-lasting noncompetitive alpha-adrenergic blockade of the postganglionic synapses in smooth muscle.

Phentolamine (Regitine)

 

Alpha-1 and alpha-2 adrenergic blocking agent that blocks circulating epinephrine and norepinephrine action.

Previous
Next

Alpha-adrenergic agonists

Class Summary

May act to decrease muscle tone.

Clonidine (Catapres)

 

Stimulates alpha2-adrenoreceptors in brain stem, activating an inhibitory neuron, which in turn results in reduced sympathetic outflow.

Guanethidine (Ismelin)

 

Acts on postganglionic fibers at the presynaptic level, releasing noradrenaline and inhibiting reuptake and rerelease. Fiscat et al reported good results in 63% of cases; Bensigner et al reported good results in 58.6% of cases.

For administration, IV access is gained as close as possible to the involved part. A BP cuff is tied well above the site of pain and inflated above the systolic pressure; a second BP cuff is tied below the first cuff as in a Bier block. Pressure is maintained for 20 min, the limb manipulated, and pressure is reduced while alternating between the 2 cuffs.

Six blocks are performed on alternate days with rigorous rehabilitation; repeated blocks even if the first block fails.

Previous
Next

Calcium channel blockers

Class Summary

Inhibit calcium ions from entering slow channels; select voltage-sensitive areas, or vascular smooth muscle.

Nifedipine (Adalat, Procardia)

 

May have a relaxant effect on certain muscles. Inhibits transmembrane influx of calcium ions into smooth muscle, which, in turn, inhibits contraction of the muscle fibers.

Amlodipine (Norvasc)

 

May have a relaxant effect on certain muscles. Inhibits transmembrane influx of calcium ions into smooth muscle, which, in turn, inhibits contraction of the muscle fibers.

Previous
Next

Corticosteroids

Class Summary

Have anti-inflammatory properties and cause profound and varied metabolic effects. Corticosteroids modify the body's immune response to diverse stimuli.

Prednisolone (Articulose-50, Delta-Cortef, Pediapred)

 

Decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reducing capillary permeability.

Previous
Next

Anesthetics

Class Summary

Local anesthetics stabilize the neuronal membrane and prevent the initiation and transmission of nerve impulses.

Lidocaine (Anestacon, Dermaflex, Lidoderm, Zilactin-L)

 

Decreases permeability to sodium ions in neuronal membranes. This results in the inhibition of depolarization, blocking the transmission of nerve impulses.

Previous
Next

Tricyclic antidepressants

Class Summary

A complex group of drugs that have central and peripheral anticholinergic effects and sedative effects. They have central effects on pain transmission. They block the active reuptake of norepinephrine and serotonin.

Amitriptyline (Elavil)

 

Analgesic for certain chronic and neuropathic pain.

Previous
Next

Analgesics

Class Summary

Pain control is essential to quality patient care. Analgesics ensure patient comfort, promote pulmonary toilet, and have sedating properties, which are beneficial for patients who experience pain.

Codeine

 

Binds to opiate receptors in CNS, causing inhibition of ascending pain pathways, altering perception and response to pain.

Previous
Proceed to Follow-up
 
 
Contributor Information and Disclosures
Author

Satishchandra Kale  MD, FRCS(UK), FRCS (Tr.& Orth.), M.Ch (Orth.), Diploma in Sports and Exercise Medicine(UK), MS(Orthopaedics), D.Ortho, MBA (International Business)

Satishchandra Kale is a member of the following medical societies: Bombay Orthopedic Society, British Orthopaedic Association, and Royal College of Surgeons of Edinburgh

Disclosure: Nothing to disclose.

Specialty Editor Board

James F Kellam, MD  Vice-Chair, Department of Orthopedic Surgery, Director of Orthopedic Trauma and Education, Carolinas Medical Center

James F Kellam, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, Orthopaedic Trauma Association, and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Samuel Agnew, MD, FACS  Associate Professor, Departments of Orthopedic Surgery and Surgery, Chief of Orthopedic Trauma, University of Florida at Jacksonville College of Medicine; Consulting Surgeon, Department of Orthopedic Surgery, McLeod Regional Medical Center

Samuel Agnew, MD, FACS is a member of the following medical societies: American Association for the Surgery of Trauma, American College of Surgeons, Orthopaedic Trauma Association, and Southern Orthopaedic Association

Disclosure: Nothing to disclose.

Dinesh Patel, MD, FACS  Associate Clinical Professor of Orthopedic Surgery, Harvard Medical School; Chief of Arthroscopic Surgery, Department of Orthopedic Surgery, Massachusetts General Hospital

Dinesh Patel, MD, FACS is a member of the following medical societies: American Academy of Orthopaedic Surgeons

Disclosure: Nothing to disclose.

Chief Editor

Mary Ann E Keenan, MD  Professor, Vice Chair for Graduate Medical Education, Department of Orthopedic Surgery, University of Pennsylvania School of Medicine; Chief of Neuro-Orthopedics Program, Department of Orthopedic Surgery, Hospital of the University of Pennsylvania

Mary Ann E Keenan, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Orthopaedic Surgeons, American Orthopaedic Association, American Orthopaedic Foot and Ankle Society, American Society for Surgery of the Hand, and Orthopaedic Rehabilitation Association

Disclosure: Nothing to disclose.

References
  1. Leriche R. The Surgery of Pain. London:. BailliereTindall & Cox;1939.

  2. Naleschinski D, Baron R. Complex Regional Pain Syndrome Type I: Neuropathic or Not?. Curr Pain Headache Rep. May 12 2010;[Medline].

  3. Koman LA, Poehling GG, Smith TL. Complex regional pain syndromes: Reflex sympathetic dystrophy and causalgia. In: Green DP, Lampert R, eds. Greens Operative Hand Surgery. 4th ed. Churchill Livingstone;1998:636-62.

  4. Mitchell SW, Morehouse GR, Keen WW. Gunshot Wounds and Other Injuries of Nerves. Philadelphia:. JB Lipincott;1864.

  5. Mitchell SW. Injuries of Nerves and their Consequences. Philadelphia:. JB Lippincott;1972.

  6. Clinical Orthopaedics. Reflex sympathetic dystrophy. In: Bailliere's Clinical Orthopaedics. Vol 1. WB Saunders Co;1996.

  7. Bonica JJ, ed. The Management of Pain. 2nd ed. Philadelphia:. Lea & Febiger;1990:220-243.

  8. Allen G, Galer BS, Schwartz L. Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients. Pain. Apr 1999;80(3):539-44. [Medline].

  9. Wilder RT, Berde CB, Wolohan M, et al. Reflex sympathetic dystrophy in children. Clinical characteristics and follow-up of seventy patients. J Bone Joint Surg Am. Jul 1992;74(6):910-9. [Medline].

  10. Ackerman WE 3rd, Ahmad M. Recurrent postoperative CRPS I in patients with abnormal preoperative sympathetic function. J Hand Surg [Am]. Feb 2008;33(2):217-22. [Medline].

  11. Herlyn P, Müller-Hilke B, Wendt M, Hecker M, Mittlmeier T, Gradl G. Frequencies of polymorphisms in cytokines, neurotransmitters and adrenergic receptors in patients with complex regional pain syndrome type I after distal radial fracture. Clin J Pain. Mar-Apr 2010;26(3):175-81. [Medline].

  12. Bernateck M, Karst M, Gratz KF, Meyer GJ, Fischer MJ, Knapp WH, et al. The first scintigraphic detection of tumor necrosis factor-alpha in patients with complex regional pain syndrome type 1. Anesth Analg. Jan 2010;110(1):211-5. [Medline].

  13. Wesseldijk F, Fekkes D, Huygen FJ, Bogaerts-Taal E, Zijlstra FJ. Increased plasma serotonin in complex regional pain syndrome type 1. Anesth Analg. Jun 2008;106(6):1862-7. [Medline].

  14. Higashimoto T, Baldwin EE, Gold JI, Boles RG. Reflex sympathetic dystrophy: complex regional pain syndrome type I in children with mitochondrial disease and maternal inheritance. Arch Dis Child. May 2008;93(5):390-7. [Medline].

  15. Genant HK, Kozin F, Bekerman C, et al. The reflex sympathetic dystrophy syndrome. A comprehensive analysis using fine-detail radiography, photon absorptiometry, and bone and joint scintigraphy. Radiology. Oct 1975;117(1):21-32. [Medline].

  16. Gellman H. Reflex sympathetic dystrophy: alternative modalities for pain management. Instr Course Lect. 2000;49:549-57. [Medline].

  17. van Laere M, Claessens M. The treatment of reflex sympathetic dystrophy syndrome: current concepts. Acta Orthop Belg. 1992;58 Suppl 1:259-61. [Medline].

  18. Albazaz R, Wong YT, Homer-Vanniasinkam S. Complex regional pain syndrome: a review. Ann Vasc Surg. Mar 2008;22(2):297-306. [Medline].

  19. Zollinger PE, Tuinebreijer WE, Breederveld RS, Kreis RW. Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures? A randomized, controlled, multicenter dose-response study. J Bone Joint Surg Am. July 2007;89(7):1424-31. [Medline].

  20. Ek JW, van Gijn JC, Samwel H, van Egmond J, Klomp FP, van Dongen RT. Pain exposure physical therapy may be a safe and effective treatment for longstanding complex regional pain syndrome type 1: a case series. Clin Rehabil. Dec 2009;23(12):1059-66. [Medline].

  21. Inchiosa MA Jr, Kizelshteyn G. Treatment of complex regional pain syndrome type I with oral phenoxybenzamine: rationale and case reports. Pain Pract. Mar-Apr 2008;8(2):125-32. [Medline].

  22. van Eijs F, Geurts J, van Kleef M, Faber CG, Perez RS, Kessels AG, et al. Predictors of pain relieving response to sympathetic blockade in complex regional pain syndrome type 1. Anesthesiology. Jan 2012;116(1):113-21. [Medline].

  23. Birch R. Pain. In: Surgical Disorders of the Peripheral Nerves. Churchill Livingstone;1994:385-93.

  24. Tan AK, Duman I, Taskaynatan MA, Hazneci B, Kalyon TA. The effect of gabapentin in earlier stage of reflex sympathetic dystrophy. Clin Rheumatol. Apr 2007;26(4):561-5. [Medline].

Previous
Next
 
Reflex sympathetic dystrophy following surgery for Dupuytren contracture.
Radiograph of affected extremity, depicting regional osteopenia contrasted with normal radiographic appearance of the opposite extremity.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.